Biotechnology Portfolio Biotechnology Fund Fundamentals
| FBIOX Fund | USD 19.49 0.18 0.93% |
Biotechnology Portfolio Biotechnology fundamentals help investors to digest information that contributes to Biotechnology Portfolio's financial success or failures. It also enables traders to predict the movement of Biotechnology Mutual Fund. The fundamental analysis module provides a way to measure Biotechnology Portfolio's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Biotechnology Portfolio mutual fund.
Biotechnology |
Biotechnology Portfolio Biotechnology Mutual Fund Price To Sales Analysis
Biotechnology Portfolio's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Biotechnology Portfolio Price To Sales | 7.71 X |
Most of Biotechnology Portfolio's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Biotechnology Portfolio Biotechnology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Biotechnology Portfolio Biotechnology has a Price To Sales of 7.71 times. This is much higher than that of the Fidelity Investments family and significantly higher than that of the Health category. The price to sales for all United States funds is notably lower than that of the firm.
Biotechnology Portfolio Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Biotechnology Portfolio's current stock value. Our valuation model uses many indicators to compare Biotechnology Portfolio value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Biotechnology Portfolio competition to find correlations between indicators driving Biotechnology Portfolio's intrinsic value. More Info.Biotechnology Portfolio Biotechnology is one of the top funds in price to earning among similar funds. It also is one of the top funds in price to book among similar funds fabricating about 0.12 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Biotechnology Portfolio Biotechnology is roughly 8.52 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Biotechnology Portfolio's earnings, one of the primary drivers of an investment's value.Biotechnology Price To Sales Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Biotechnology Portfolio's direct or indirect competition against its Price To Sales to detect undervalued stocks with similar characteristics or determine the mutual funds which would be a good addition to a portfolio. Peer analysis of Biotechnology Portfolio could also be used in its relative valuation, which is a method of valuing Biotechnology Portfolio by comparing valuation metrics of similar companies.Biotechnology Portfolio is currently under evaluation in price to sales among similar funds.
Fund Asset Allocation for Biotechnology Portfolio
The fund consists of 96.05% investments in stocks, with the rest of investments allocated between different money market instruments and various exotic instruments.Asset allocation divides Biotechnology Portfolio's investment portfolio among different asset categories to balance risk and reward by investing in a diversified mix of instruments that align with the investor's goals, risk tolerance, and time horizon. Mutual funds, which pool money from multiple investors to buy a diversified portfolio of securities, use asset allocation strategies to manage the risk and return of their portfolios.
Mutual funds allocate their assets by investing in a diversified portfolio of securities, such as stocks, bonds, cryptocurrencies and cash. The specific mix of these securities is determined by the fund's investment objective and strategy. For example, a stock mutual fund may invest primarily in equities, while a bond mutual fund may invest mainly in fixed-income securities. The fund's manager, responsible for making investment decisions, will buy and sell securities in the fund's portfolio as market conditions and the fund's objectives change.
Biotechnology Fundamentals
| Price To Earning | 29.21 X | ||||
| Price To Book | 3.43 X | ||||
| Price To Sales | 7.71 X | ||||
| Annual Yield | 0.01 % | ||||
| Year To Date Return | 0.85 % | ||||
| One Year Return | 6.51 % | ||||
| Three Year Return | 6.77 % | ||||
| Five Year Return | 4.67 % | ||||
| Ten Year Return | 19.82 % | ||||
| Net Asset | 4.78 B | ||||
| Last Dividend Paid | 0.03 | ||||
| Cash Position Weight | 0.41 % | ||||
| Equity Positions Weight | 96.05 % |
About Biotechnology Portfolio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Biotechnology Portfolio Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Biotechnology Portfolio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Biotechnology Portfolio Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this mutual fund, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.The fund invests primarily in common stocks. It normally invests at least 80 percent of assets in securities of companies principally engaged in the research, development, manufacture, and distribution of various biotechnological products, services, and processes and companies that benefit significantly from scientific and technological advances in biotechnology. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuers financial condition and industry position, as well as market and economic conditions to select investments. The fund is non-diversified.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Biotechnology Mutual Fund
Biotechnology Portfolio financial ratios help investors to determine whether Biotechnology Mutual Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Biotechnology with respect to the benefits of owning Biotechnology Portfolio security.
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios |